eIF4G (C65H5) Rabbit mAb 2617S from Cell Signaling Technology

Product Specs
ItemeIF4G (C65H5) Rabbit mAb
CompanyCell Signaling Technology
Price $336.00 Inquire
Catalog Number2617S
Quantity100 µl
ApplicationsW
ReactivityH, M, R, Mk
TargeteIF4G
HostRabbit
NCBI Gene AliasesEIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18
ClonalityMonoclonal
NCBI Full Gene Nameeukaryotic translation initiation factor 4 gamma 1
Research AreaTranslational Control
IsotypeIgG
CloneC65H5
Molecular Weight220

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Loss of SCRG1 in chondrocytes inhibits osteoarthritis by promoting autophagy activity in the temporomandibular joint through inhibition of neurokine receptorsJ Oral Facial Pain HeadacheMarch 12, 2025JiaJun Zhang, LePing Yuan, YanYan Zhang, HaoYang Jin, YeKe Zhao, XiaoKe Zeng, YanHui Zou, KeYu Wang, Xin Nieantibody (7074, CST, Boston, MA, USA). Protein bands were detected using the ChemiDocTM XRS system (PX 2617, Bio-Rad, Heracles, CA, USA) after being contacted with electrochemiluminescence (ECL) solvent (G2014,

(2) Translation of SARS-CoV-2 gRNA Is Extremely Efficient and Competitive despite a High Degree of Secondary Structures and the Presence of an uORFVirusesJuly 8, 2022Lionel CondÃ©, Omran Allatif, ThÃ©ophile Ohlmann, Sylvain de Breyne(Boehringer Mannheim, Ingelheim am Rhein, Germany). Blots were incubated first with antibody against eIF4G (#2617 Cell Signaling Technology, Danvers, MA, USA) for 16 h at 4 °C, then with an anti-Rabbit IgG–Peroxidase

(3) Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice ProvidersRheumatology and TherapyDecember 1, 2021William Saalfeld, Amanda M. Mixon, Jonna Zelie, Eileen J. Lydonof diagnosis, with domain presentation ranges from 12.6% to 85% [142]. Furthermore, in a study among 2617 patients with established PsA [mean (SD) disease duration of 8.5 (8.1) years] enrolled in a registry

(4) The distribution of eukaryotic initiation factor 4E after bouts of resistance exercise is altered by shortening of recovery periodsThe Journal of Physiological SciencesDecember 1, 2020Junya Takegaki, Riki Ogasawara, Karina Kouzaki, Satoshi Fujita, Koichi Nakazato, Naokata IshiirpS6 (#2217; CST), p-4EBP1 (Thr37/46, #9459; CST), 4EBP1 (#9644; CST), eIF4E (#2067; CST), eIF4G (#2617; CST), eIF4A (#2013; CST), eIF4H (#3469; CST), p-eEF2 (Thr56, #2331; CST), eEF2 (#2332; CST), p-eIF4B

(5) Multiplicity among solar-type starsAstronomy & AstrophysicsNovember 1, 2018J.-L. Halbwachs, M. Mayor, S. Udry361 0.88 0.86 1.30 1.18 0.78 0.90 0.83 1.15 1.12 0.88 0.91 1.00 0.97 1.22 0.82 1.17 0.89 1.12 1.02 1.19 0.92 1.01 1.06 1.04 1.30 1.10 0.84 0.83 1.32 1.01 1.25 0.81 0.94 1.02 1.24 1.05 1.36 1.13 0.99 1.08 0.96 0.95 1.10 0.96 1.33 0.95 1.04 1.28 1.14 1.12 0.82 1.08 0.94 1.39 1.11 1.26 0.73 1.38 16.31 22.24 2.58 83.73 50.66 51.19 38.95 17.69 3.64 −25.89 −13.57 23.99 56.51 25.23 −42.52 −78.60 45.06 35.51 −27.57 1.01 17.67 26.24 21.45 87.84 53.71 −55.72 1.35 −29.17 22.87 −33.80 −1.90 −9.75 −8.92 −44.29 19.44 −7.20 −14.95 −5.84 −21.51 −30.81 26.44 −3.98 66.03 −18.21 −19.02 −15.91 −4.34 20.35 13.47 20.22 −12.03 54.61 −23.63 43.52 −50.36 −27.09 49.99 −11.34 0.06 0.04 0.14 0.13 0.12 0.06 0.12 0.10 0.11 0.13 0.10 0.12 0.11 0.02 0.07 0.13 0.09 0.04 0.08 0.06 0.10 0.13 0.07 0.09 0.14 0.11 0.09 0.09 0.18 0.13 0.13 0.09 0.08 0.10 0.14 0.11 0.15 0.39 0.11 0.12 0.12 0.09 0.12 0.09 0.14 0.10 0.13 0.19 0.10 0.13 0.11 0.13 0.15 0.97 0.14 0.16 0.07 0.19 0.28 3.94 0.20 0.10 0.40 7.08 0.23 0.20 0.29 0.53 0.30 0.25 0.36 0.85 0.35 0.37 4.86 7.70 3.23 0.32 0.24 0.29 0.24 0.22 0.57 0.36 0.35 0.27 0.50 0.33 0.20 0.24 42.25 0.12 0.46 0.39 0.40 1.47 0.28 0.30 0.33 0.24 0.26 0.31 0.43 3.97 0.37 0.55 0.31 0.22 0.25 0.19 0.41 2.92 0.14 0.46 8.50 0.56 1.02 12.38 0.48 0.28 1.03 18.94 0.70 0.62 0.85 1.16 0.94 0.74 1.00 2.15 1.16 0.97 15.09 22.48 8.65 1.00 0.74 0.80 0.82 0.71 1.55 1.16 1.15 0.84 1.10 0.92 0.52 0.78 139.71 0.36 1.27 1.29 0.90 3.45 0.86 0.85 0.93 0.82 0.71 1.02 1.10 12.55 1.10 1.33 0.97 0.61 0.75 0.53 1.22 3.27 0.35 1.03 11.27 1.25 0.407 0.000 0.986 0.999 0.388 0.000 0.842 0.945 0.687 0.173 0.552 0.804 0.448 0.000 0.131 0.480 0.000 0.000 0.000 0.482 0.845 0.721 0.839 0.886 0.002 0.211 0.186 0.768 0.302 0.560 0.977 0.816 0.000 0.999 0.107 0.076 0.603 0.000 0.664 0.688 0.553 0.776 0.860 0.418 0.289 0.000 0.294 0.103 0.499 0.925 0.808 0.962 0.182 0.000 0.997 0.409 0.000 0.149 21 38 9 8 11 29 8 10 9 17 10 8 10 25 22 8 26 54 24 30 10 8 18 11 17 10 14 14 8 8 9 11 41 11 11 12 9 14 9 9 9 12 9 11 10 24 8 8 10 8 9 8 7 9 8 8 56 9 21 38 9 8 11 29 8 10 9 17 10 8 10 25 22 8 26 54 24 30 10 8 18 11 17 10 14 14 8 8 9 11 46 11 11 12 9 14 9 9 9 12 9 11 10 24 8 8 10 8 9 8 7 18 8 8 101 9 3989 5585 3984 2889 6113 3344 2265 3245 3405 5564 3245 3136 3410 5223 5913 3248 5517 2492 3306 5840 3245 2891 4164 2628 5409 2628 4802 3140 3425 3399 3256 4815 5603 3072 2943 3238 4410 5416 3071 2561 4611 2601 2615 4760 4760 6124 2958 3984 2617 3277 3591 3303 3593 5516 3936 5056 5391 4050 CST SB1O CST CST CST SB1O1 CST CST CST CST CST CST CST SB1O CST CST SB1O SB1O SB1O CST CST CST CST CST SB1? CST CST CST CST CST CST CST SB2O CST CST CST CST SB1 CST CST CST CST CST CST CST SB1O CST CST CST CST CST CST CST SB2 CST CST SB2O CST * * + + * + * + A81,

(6) Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcomaOncotargetJanuary 5, 2018Pain M, Wang H, Lee E, Strahl M, Hamou W, Sebra R, Zhu J, Yong RL.was performed on formalin-fixed, paraffin-embedded slides in a CLIA-approved pathology laboratory. 2617 Oncotarget Immunofluorescence of gliomasphere cells was performed as previously described [30].

(7) NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanomaOncogeneJuly 6, 2017Zhai Z, Liu W, Kaur M, Luo Y, Domenico J, Samson JM, Shellman YG, Norris DA, Dinarello CA, Spritz RA, et al.

(8) Poly(A) tail length regulates PABPC1 expression to tune translation in the heartElifeJune 27, 2017Sandip Chorghade, Joseph Seimetz, Russell Emmons, Jing Yang, Stefan M Bresson, Michael De Lisio, Gianni Parise, Nicholas K Conrad, Auinash Kalsotrawere separated by 8% SDS-PAGE, transferred to PVDF membranes, and detected with anti-eIF4G1 antibody (#2617, Cell Signaling Technology). Adenovirus design and use Adenovirus was produced using the methodology

(9) Poly(A) tail length regulates PABPC1 expression to tune translation in the hearteLifeJune 27, 2017Sandip Chorghade, Joseph Seimetz, Russell Emmons, Jing Yang, Stefan M Bresson, Michael De Lisio, Gianni Parise, Nicholas K Conrad, Auinash Kalsotrawere separated by 8% SDS-PAGE, transferred to PVDF membranes, and detected with anti-eIF4G1 antibody (#2617, Cell Signaling Technology). Adenovirus design and use Adenovirus was produced using the methodology

(10) Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteinsOncology lettersJune 1, 2017Pan X, Yang X, Zang J, Zhang S, Huang N, Guan X, Zhang J, Wang Z, Li X, Lei X.saline with Tween-20 and 5% powdered milk, the membranes were incubated with anti-eIF4G (cat. no., 2617S; dilution, 1:1,000) and anti-β-actin (cat. no., 8457S; dilution, 1:1,000) antibodies purchased from

(11) Mitochondrial Ribosomal Protein L10 Associates with Cyclin B1/Cdk1 Activity and Mitochondrial FunctionDNA and Cell BiologyNovember 1, 2016Hai-Bo Li, Ruo-Xi Wang, Hai-Bo Jiang, En-dong Zhang, Jie-Qiong Tan, Hui-Zhuo Xu, Rong-rong Zhou, Xiao-Bo Xia

(12) Fine-scale spatial ecology drives kin selection relatedness among cooperating amoebaeEvolutionApril 1, 2016jeff smith, Joan E. Strassmann, David C. Quellerpromote or inhibit the evolution of helping behaviours. Phil. Trans. Roy. Soc. B: Biol. Sci. 365:2599-2617. 595 Loomis, W. F. 2014. Cell signaling during development of Dictyostelium. Dev. Biol. 391:1-16. Mehdiabadi,

(13) CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetaseNatureOctober 29, 2015He W, Bai G, Zhou H, Wei N, White NM, Lauer J, Liu H, Shi Y, Dumitru CD, Lettieri K, et al.

Be the First to Write a Review!

eIF4G (C65H5) Rabbit mAb

eIF4G (C65H5) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (13)

Reviews

eIF4G (C65H5) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map